雪榕生物(300511) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for the third quarter was ¥534,255,898.88, a decrease of 6.30% compared to the same period last year, and a year-to-date revenue of ¥1,324,930,751.78, down 19.26% year-on-year[6]. - Net profit attributable to shareholders was ¥40,203,669.22, an increase of 298.87% year-on-year, while the year-to-date net profit was a loss of ¥62,348,351.93, improving by 61.94% compared to the previous year[6]. - The basic and diluted earnings per share for the quarter were both ¥0.07, reflecting a 275.00% increase year-on-year, while the year-to-date figure was a loss of ¥0.11, improving by 66.67%[6]. - The company reported a net loss of CNY 527,101,204.31, compared to a loss of CNY 464,752,852.38 in the previous period[25]. - The company reported a net loss of ¥56,207,159.98 for the current period, compared to a net loss of ¥155,325,617.05 in the previous period, indicating an improvement[28]. - The company’s total comprehensive income for the current period was -¥55,442,212.74, compared to -¥154,937,680.21 in the previous period, indicating a reduction in losses[28]. - Basic and diluted earnings per share were both reported at -¥0.11, an improvement from -¥0.33 in the previous period[28]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,601,440,662.94, a decrease of 6.57% from the end of the previous year[6]. - Total liabilities decreased to CNY 2,252,631,308.40 from CNY 3,031,232,610.38, a decline of 25.7%[25]. - The company's equity attributable to shareholders increased by 55.22% to ¥1,456,940,504.02 compared to the end of the previous year[6]. - The company's equity attributable to shareholders increased to CNY 1,456,940,504.02 from CNY 938,628,711.97, an increase of 55.3%[25]. - Non-current assets decreased to CNY 3,056,209,472.11 from CNY 3,308,246,402.94, a decline of 7.6%[24]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥248,156,943.68, an increase of 5.83%[6]. - Cash flow from operating activities generated a net cash inflow of ¥248,156,943.68, compared to ¥234,487,961.21 in the previous period, showing a slight increase[29]. - The company experienced a significant decrease in cash flow from investing activities, with a net outflow of -¥42,832,187.28, compared to -¥287,305,326.58 in the previous period[30]. - Cash flow from financing activities resulted in a net outflow of -¥250,337,152.32, a decrease from a net inflow of ¥57,610,655.52 in the previous period[30]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 28,647[15]. - The largest shareholder, Yang Yongping, holds 17.16% of shares, totaling 107,606,850 shares[15]. - Zhejiang Yinwan Private Fund Management Co., Ltd. holds 2.99% of shares, totaling 18,734,600 shares[15]. - The total number of restricted shares held by Yang Yongping is 80,705,137, which remains unchanged due to executive lock-up regulations[18]. - The company has a total of 80,792,999 restricted shares at the end of the reporting period, with 20,925 shares newly restricted[18]. - The company has not disclosed any changes in the top 10 shareholders due to margin trading activities[16]. Control Change and Agreements - The company has signed a framework agreement for control change with Shanghai Wanzihong Intelligent Technology Co., Ltd., involving share transfer and voting rights delegation[20]. - The agreement for share transfer has received confirmation from the Shenzhen Stock Exchange, but the completion of the transaction remains uncertain[21]. - The company is in the process of finalizing the transfer of control, which may impact future financing and governance[21]. Operational Metrics - Total operating revenue for the current period is CNY 1,324,930,751.78, a decrease of 19.2% compared to CNY 1,641,052,971.34 in the previous period[26]. - Total operating costs for the current period amount to CNY 1,403,701,115.19, down 22.6% from CNY 1,812,691,932.39 in the previous period[26]. - The company's cash and cash equivalents decreased to CNY 104,968,184.35 from CNY 167,953,803.72, representing a decline of 37.5%[23]. - Accounts receivable increased to CNY 36,326,690.57 from CNY 31,390,843.09, reflecting a growth of 15.5%[23]. - Inventory rose to CNY 373,450,732.37 from CNY 325,337,429.69, indicating an increase of 14.8%[23]. - Short-term borrowings decreased significantly to CNY 320,338,213.13 from CNY 967,853,695.34, a reduction of 66.9%[24]. - The company did not report any net profit from subsidiaries prior to consolidation, indicating no contribution from merged entities[28]. - The company's operating profit was reported at -¥53,581,230.12, an improvement from -¥155,204,345.16 in the previous period[28].